No disrespect, but the underlying cause of this selloff isnโt driven by any of the reasons you provided.
I am not easily impressed by a broken clock being right on time twice a day.
Best of luck and no hate.
$NU growth story in a nutshell. I'm ok with cost to serve rising by 10% while revenue growth 20% in same quarter.
Perhaps the only concern for me is the default rate rises above 7%. Would probably be worst as they expand.
@Matkinvest Yes it is! Are u also invested early?
The one thing that concerns me really is credit risk. Maybe because in Singapore, the risk is relatively low so the comfort level matters abit.
Here is what worries me.
This is not the first promise of a carry step up. It was meant to show in 2023, then 2024. Both slipped.
Now the story is 2027. If it moves again, the 20% starts to look like optimism in the plan, not conservatism.
That is the real risk in holding $BN.
$BN has a 20% a year earnings target.
Strip out performance fees and it compounds a steady ~10%.
Add them back, the number the target is measured on, and it is flat since 2024.
The carry only shows up when they sell. And they keep deferring it to 2027.
Why this one line matters so much:
Carry is almost pure profit. It costs them nothing to earn.
It is also the growth. The fees, insurance and operating arms already compound mid teens. Carry is what takes the headline to 20%+.
No carry, no premium.
On another point about Sea Cloud. If one tracks back history SEA AI Lab was form in 2021 to push the frontiers of AI research and develop leading technologies in the field.
Refer to news. https://t.co/t4wfpplVep
I'm still holding because no thesis breaking in this quarter. But my concern is what will happen in the nexxt 1 to 3 years when Monee spinoff.
A separate listing can unlock value, but it can also pull investors to the fintech and leave the parent behind.
@RAWZackZhu On Monee, when they start to IPO, do you foresee it will drag SE prices because from valuation pov, we cant really use Monee to calculate them anymore because they will be sort of indirect relationship.
While I get the need to breakaway for captial, not sure if its best for us
And that recurring base has grown every single year since 2016, usually 4 to 6% a year.
2026 is softer, dragged by customer attrition at one acquired business, Altera, that management expects to clear by end 2027.
Customers keep paying. That is the whole thesis.
The scary number everyone quoted: total organic growth of just 2%.
But that is everything lumped together. The part that matters, recurring revenue (77% of sales), grew 4% organically. Strip out one troubled healthcare unit and it was 5%.
So the quarter is reassuring: strong capital, clean books, dividends safe and DBS still raising its payout.
The concern isnโt safety. Itโs entry yield. You are paying up for that income now, not buying it cheap.
SG banks Q3'26, a dividend lens.
Earnings quality was mixed: OCBC steady, DBS soft on trading, UOB flattered by a weak year ago base. But the payouts look safe across all 3.
The catch for income buyers: even after this weekโs dip, none yields near 5%.
Trailing yields right now (approx.):
DBS 4.56%
UOB 4.31%
OCBC 3.21%
These stocks used to pay 5% to 6%. The rally pushed prices so high that the yields fell below 5%, and this weekโs dip barely moved them.